| 6 |
8,076,357 |
 |
Compositions of
n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-
-3-carboxamide
|
| 7 |
8,076,343 |
 |
Benzimidazoles useful as inhibitors of protein kinases
|
| 8 |
8,071,618 |
 |
Caspase inhibitors and uses thereof
|
| 9 |
8,071,318 |
 |
High throughput method and system for screening candidate compounds for
activity against target ion channels
|
| 10 |
8,067,606 |
 |
Gyrase inhibitors and uses thereof
|
| 11 |
8,067,417 |
 |
Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases
|
| 12 |
8,058,271 |
 |
Selective inhibitors of rock protein kinase and uses thereof
|
| 13 |
8,039,661 |
 |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
| 14 |
8,039,623 |
 |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
| 15 |
8,039,491 |
 |
Modulators of ATP-binding cassette transporters
|
| 16 |
8,039,475 |
 |
Co-crystals and pharmaceutical compositions comprising the same
|
| 17 |
8,034,950 |
 |
Processes for the facile synthesis of diaryl amines and analogues thereof
|
| 18 |
8,034,832 |
 |
Gyrase inhibitors and uses thereof
|
| 19 |
8,022,202 |
 |
Dihydrodiazepines useful as inhibitors of protein kinases
|
| 20 |
8,022,041 |
 |
Prodrug of an ICE inhibitor
|
| 21 |
8,017,781 |
 |
Azaindazoles useful as inhibitors of kinases
|
| 22 |
8,017,619 |
 |
Compositions useful as inhibitors of protein kinases
|
| 23 |
8,012,999 |
 |
Modulators of CFTR
|
| 24 |
8,003,685 |
 |
Thiophene analogues for the treatment or prevention of flavivirus
infections
|
| 25 |
8,003,660 |
 |
Modulators of muscarinic receptors
|
| 26 |
8,002,891 |
 |
Crystallization of C-Jun N-Terminal Kinase 3 (JNK3)
|
| 27 |
7,999,113 |
 |
Modulators of cystic fibrosis transmembrane conductance regulator
|
| 28 |
7,998,987 |
 |
Inhibitors of c-Met and uses thereof
|
| 29 |
7,994,174 |
 |
Pyridyl sulfonamides as modulators of ion channels
|
| 30 |
7,994,166 |
 |
Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels
for the treatment of pain
|
| 31 |
7,989,498 |
 |
Inhibitors of IMPDH enzyme
|
| 32 |
7,989,481 |
 |
Indane derivatives as modulators of ion channels
|
| 33 |
7,989,456 |
 |
Pyrazine kinase inhibitors
|
| 34 |
7,985,769 |
 |
Compounds and methods for the treatment or prevention of Flavivirus
infections
|
| 35 |
7,985,762 |
 |
Inhibitors of serine proteases
|
| 36 |
7,982,037 |
 |
Pyrazole compounds useful as protein kinase inhibitors
|
| 37 |
7,977,322 |
 |
Modulators of ATP-binding cassette transporters
|
| 38 |
7,973,169 |
 |
Modulators of ATP-Binding Cassette transporters
|
| 39 |
7,973,162 |
 |
Modulators of muscarinic receptors
|
| 40 |
7,973,038 |
 |
Modulators of ATP-binding cassette transporters
|
| 41 |
7,972,813 |
 |
Tetrodotoxin-resistant sodium channel alpha subunit
|
| 42 |
7,968,716 |
 |
Caspase inhibitors and uses thereof
|
| 43 |
7,968,545 |
 |
Compositions useful as inhibitors of voltage-gated ion channels
|
| 44 |
7,964,624 |
 |
Inhibitors of serine proteases
|
| 45 |
7,960,398 |
 |
Regulation of TNF-alpha
|
| 46 |
7,956,052 |
 |
Modulators of ATP-binding cassette transporters
|
| 47 |
7,951,820 |
 |
Triazole compounds useful as protein kinase inhibitors
|
| 48 |
7,951,809 |
 |
Inhibitors of p38
|
| 49 |
7,943,593 |
 |
Compositions comprising inhibitors of IMPDH enzyme
|
| 50 |
7,928,107 |
 |
Quinazolines useful as modulators of ion channels
|